Stock NOVO B NOVO NORDISK A/S
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Real-time Estimate Cboe Europe
Other stock markets
 05:28:15 2024-05-17 am EDT 		5-day change 1st Jan Change
906.6 DKK -0.69% Intraday chart for Novo Nordisk A/S -0.26% +30.00%
May. 16 Health Care Flat as Momentum Wanes -- Health Care Roundup DJ
May. 16 Novo Nordisk Reports Fire Incident at Under-Construction Facility in Kalundborg, Denmark MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GL
Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial
GL
Tampere University : Novo Nordisk Foundation grants 670 000 EUR to develop organ transplant assessment and drug discovery tool for epilepsy
AQ
Equity Research | NANEXA: Insights from CMD underscore near- to mid-term opportunities with significant potential
AQ
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GL
FORGET HANDBAGS, OZEMPIC'S IN
AQ
Trading in Novo Nordisk shares by board members, executives and associated persons
GL
Novo Nordisk A/S - share repurchase programme
GL
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
GL
Ventus Therapeutics Announces First Participant Dosed in Clinical Study with an NLRP3 Inhibitor Licensed Exclusively to Novo Nordisk
AQ
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GL
Nanexa publishes interim report for January-March 2024
AQ
Weight-loss drug Wegovy available in Canada starting May 6 for people with obesity
AQ
Novo Nordisk A/S : Go to the Q1 2024 company announcement
PU
Novo Nordisk A/S : Open the Q1 2024 investor presentation
PU
Novo Nordisk: Q1 Earnings Snapshot
AQ
Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates to DKK 65.3 billion in the first three months of 2024
GL
Novo Nordisk A/S - share repurchase programme
GL
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
AQ
Nanexa invites to Capital Markets Day on May 7
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. News Novo Nordisk A/S
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW